SEC Form 4 · accession 0001209191-15-038779
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Walbert
Officer — Chairman, President and CEO · Director
Period of report
May 1, 2015
Accepted (ET)
May 5, 2015 · 2:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 1, 2015 | M | 5,568 | $12.94 | A | 94,095 | D | |
| Ordinary Shares | May 1, 2015 | M | 38,348 | $10.43 | A | 132,443 | D | |
| Ordinary Shares | May 1, 2015 | M | 24,603 | $5.20 | A | 157,046 | D | |
| Ordinary Shares | May 1, 2015 | M | 18,079 | $4.96 | A | 175,125 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $12.94 | May 1, 2015 | M | 5,568 | D | — | Jun 15, 2020 | Ordinary Shares | 5,568 | 107,219 | D |
| Stock Option (Right to Buy)F1 | $10.43 | May 1, 2015 | M | 38,348 | D | — | Jul 15, 2018 | Ordinary Shares | 38,348 | 83,353 | D |
| Stock Option (Right to Buy)F1 | $5.20 | May 1, 2015 | M | 24,603 | D | — | Feb 2, 2020 | Ordinary Shares | 24,603 | 104,334 | D |
| Stock Option (Right to Buy)F2 | $4.96 | May 1, 2015 | M | 18,079 | D | — | Dec 7, 2021 | Ordinary Shares | 18,079 | 198,876 | D |
Explanation of responses
- F1The stock option is fully vested and exercisable. 25% of the shares subject to the option vested on the first anniversary of the grant date, and the remaining shares vested in 36 equal monthly installments thereafter.
- F2The stock option vests in 48 equal monthly installments following the date of grant.